Skip to main content
SpringerLink
Log in

NICE revises AD guidance, but pharma still not happy

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. NICE.NICE complies with judge's ruling on judicial review. Media Release: 7 Sep 2007. Available from: URL: http://www.nice.org.uk

  2. Shire.Revised NICE Guidance on Alzheimer's Disease (AD) Confirms Reliance on the MMSE(1) for Majority of Patients and Continued Exclusion From NHS Treatment for Those With Mild AD. Media Release: 7 Sep 2007. Available from: URL: http://www.shire.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

NICE revises AD guidance, but pharma still not happy. Pharmacoecon. Outcomes News 537, 2 (2007). https://doi.org/10.2165/00151234-200705370-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705370-00002

Keywords

Search

Navigation